Please wait a minute...
Search Asian J Urol Advanced Search
Share 
Asian Journal of Urology, 2015, 2(4): 244-245    doi: 10.1016/j.ajur.2015.09.001
  本期目录 | 过刊浏览 | 高级检索 |
Stellate scar sign of renal cell carcinoma
Weibin Hou, Guanghua Liu, Zhigang Ji
Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Stellate scar sign of renal cell carcinoma
Weibin Hou, Guanghua Liu, Zhigang Ji
Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
下载:  PDF (1703KB) 
输出:  BibTeX | EndNote (RIS)      
摘要 Stellate scar sign is defined as the centrally-placed, welldefined, stellate area of low density on computed tomography (CT) appearance of solid tumors. This kind of radiating enhancement from the center of the tumor, which is also referred as “a spoke-wheel-like enhancement” or central scar sign, usually has been recognized as a specific finding of renal oncocytoma. We describe a patient who developed clear cell renal cell carcinoma (RCC) displaying typical stellate scar sign on CT scans, which was confirmed by gross pathologic appearance.
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
Weibin Hou
Guanghua Liu
Zhigang Ji
Abstract: Stellate scar sign is defined as the centrally-placed, welldefined, stellate area of low density on computed tomography (CT) appearance of solid tumors. This kind of radiating enhancement from the center of the tumor, which is also referred as “a spoke-wheel-like enhancement” or central scar sign, usually has been recognized as a specific finding of renal oncocytoma. We describe a patient who developed clear cell renal cell carcinoma (RCC) displaying typical stellate scar sign on CT scans, which was confirmed by gross pathologic appearance.
收稿日期:  2015-01-28      修回日期:  2015-08-28           出版日期:  2015-10-01      发布日期:  2015-10-29      整期出版日期:  2015-10-01
通讯作者:  Zhigang Ji    E-mail:  jizg1129@163.com
引用本文:    
Weibin Hou, Guanghua Liu, Zhigang Ji. Stellate scar sign of renal cell carcinoma[J]. Asian Journal of Urology, 2015, 2(4): 244-245.
Weibin Hou, Guanghua Liu, Zhigang Ji. Stellate scar sign of renal cell carcinoma. Asian Journal of Urology, 2015, 2(4): 244-245.
链接本文:  
http://www.ajurology.com/CN/10.1016/j.ajur.2015.09.001  或          http://www.ajurology.com/CN/Y2015/V2/I4/244
[1] Lou L, Teng J, Lin X, Zhang H. Ultrasonographic features of renal oncocytoma with histopathologic correlation. J Clin Ultrasound 2014;42:129-33.
[2] Kondo T, Nakazawa H, Sakai F, Kuwata T, Onitsuka S, Hashimoto Y, et al. Spoke-wheel-like enhancement as an important imaging finding of chromophobe cell renal carcinoma: a retrospective analysis on computed tomography and magnetic resonance imaging studies. Int J Urol 2004;11: 817-24.
[3] Woo S, Cho JY, Kim SH, Kim SY. Comparison of segmental enhancement inversion on biphasic MDCT between small renal oncocytomas and chromophobe renal cell carcinomas. AJR Am J Roentgenol 2013;201:598-604.
[4] Leveridge MJ, Finelli A, Kachura JR, Evans A, Chung H, Shiff DA, et al. Outcomes of small renal mass needle core biopsy, nondiagnostic percutaneous biopsy, and the role of repeat biopsy. Eur Urol 2011;60:578-84.
[5] Yousef GM, Ejeckam GC, Best LM, Diamandis EP. Collecting duct carcinoma associated with oncocytoma. Int Braz J Urol 2005; 31:465-9.
No related articles found!
[1] Zhixiang Wang, Bing Liu, Xiaofeng Gao, Yi Bao, Yang Wang, Huamao Ye, Yinghao Sun, Linhui Wang. Laparoscopic ureterolysis with simultaneous ureteroscopy and percutaneous nephroscopy for treating complex ureteral obstruction after failed endoscopic intervention: A technical report[J]. Asian Journal of Urology, 2015, 2(4): 238 -243 .
[2] Louis R. Kavoussi. News from leading international academic urology departments[J]. Asian Journal of Urology, 2017, 4(1): 1 -2 .
[3] Rikiya Taoka, Yoshiyuki Kakehi. The influence of asymptomatic inflammatory prostatitis on the onset and progression of lower urinary tract symptoms in men with histologic benign prostatic hyperplasia[J]. Asian Journal of Urology, 2017, 4(3): 158 -163 .
[4] Cheuk Fan Shum, Weida Lau, Chang Peng Colin Teo. Medical therapy for clinical benign prostatic hyperplasia:a1 Antagonists, 5a reductase inhibitors and their combination[J]. Asian Journal of Urology, 2017, 4(3): 185 -190 .
[5] Foo Keong Tatt. Current consensus and controversies on male LUTS/BPH (part two)[J]. Asian Journal of Urology, 2018, 5(1): 8 -9 .
[6] Rishi R. Sekar, Claire M. De La Calle, Dattatraya Patil, Sarah A. Holzman, Yoram Baum, Umer Sheikh, Jonathan H. Huang, Adeboye O. Osunkoya, Brian P. Pollack, Haydn T. Kissick, Kenneth Ogan, Viraj A. Master. Major histocompatibility complex I upregulation in clear cell renal cell carcinoma is associated with increased survival[J]. Asian Journal of Urology, 2016, 3(2): 75 -81 .
[7] Ryan Yu, Jefferson Terry, Mutaz Alnassar, Jorge Demaria. Pediatric fibrous pseudotumor of the tunica vaginalis testis[J]. Asian Journal of Urology, 2016, 3(2): 99 -102 .
[8] Aso Omer Rashid, Saman Salih Fakhulddin. Risk factors for fever and sepsis after percutaneous nephrolithotomy[J]. Asian Journal of Urology, 2016, 3(2): 82 -87 .
[9] Christopher Hartman, Nikhil Gupta, David Leavitt, David Hoenig, Zeph Okeke, Arthur Smith. Advances in percutaneous stone surgery[J]. Asian Journal of Urology, 2015, 2(1): 26 -32 .
[10] Aldamanhori Reem,I.Osman Nadir,R.Chapple Christopher. Underactive bladder: Pathophysiology and clinical significance[J]. Asian Journal of Urology, 2018, 5(1): 17 -21 .
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed